1408. Population Pharmacokinetic (PK) Model to Describe Epithelial Lining Fluid (ELF) Penetration of ASN-1 and ASN-2 after ASN100 Administration to Healthy Subjects

od Van Wart, Scott A, Stevens, Christopher, Magyarics, Zoltan, Luperchio, Steven A, Rubino, Christopher M, Ambrose, Paul G
Wydane w Open Forum Infect Dis (2018)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

od Rubino, Christopher M., Van Wart, Scott A., Bhavnani, Sujata M., Ambrose, Paul G., McCollam, Jill S., Forrest, Alan
Wydane 2009

Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization

od Andes, David R., Reynolds, Daniel K., Van Wart, Scott A., Lepak, Alexander J., Kovanda, Laura L., Bhavnani, Sujata M.
Wydane 2013

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

od Trang, Michael, Seroogy, Julie D., Van Wart, Scott A., Bhavnani, Sujata M., Kim, Aryun, Gibbons, Jacqueline A., Ambrose, Paul G., Rubino, Christopher M.
Wydane w Antimicrob Agents Chemother (2019)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptoc...

od Van Wart, Scott A., Ambrose, Paul G., Rubino, Christopher M., Khariton, Tatiana, Riccobene, Todd A., Friedland, H. David, Critchley, Ian A., Bhavnani, Sujata M.
Wydane 2014

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

od Andes, David, Ambrose, Paul G., Hammel, Jeffrey P., Van Wart, Scott A., Iyer, Varsha, Reynolds, Daniel K., Buell, Donald N., Kovanda, Laura L., Bhavnani, Sujata M.
Wydane 2011

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

od Lakota, Elizabeth A., Van Wart, Scott A., Trang, Michael, Tzanis, Evan, Bhavnani, Sujata M., Safir, M. Courtney, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Rubino, Christopher M.
Wydane w Antimicrob Agents Chemother (2020)

Population Pharmacokinetics of Oseltamivir: Pediatrics through Geriatrics

od Kamal, Mohamed A., Van Wart, Scott A., Rayner, Craig R., Subramoney, Vishak, Reynolds, Daniel K., Bulik, Catharine C., Smith, Patrick F., Bhavnani, Sujata M., Ambrose, Paul G., Forrest, Alan
Wydane 2013

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

od Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Wydane 2013

Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients with Acute Bacterial Skin and Skin Structure Infections

od Bhavnani, Sujata M., Hammel, Jeffrey P., Van Wart, Scott A., Rubino, Christopher M., Reynolds, Daniel K., Forrest, Alan, Drusano, George L., Khariton, Tatiana, Friedland, H. David, Riccobene, Todd A., Ambrose, Paul G.
Wydane w Antimicrob Agents Chemother (2014)

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes

od Schiffer, Joshua T., Swan, David A., Magaret, Amalia, Corey, Lawrence, Wald, Anna, Ossig, Joachim, Ruebsamen-Schaeff, Helga, Stoelben, Susanne, Timmler, Burkhard, Zimmermann, Holger, Melhem, Murad R., Van Wart, Scott A., Rubino, Christopher M., Birkmann, Alexander
Wydane w Sci Transl Med (2016)

Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

od Thwaites, Guy E., Bhavnani, Sujata M., Chau, Tran Thi Hong, Hammel, Jeffrey P., Török, M. Estée, Van Wart, Scott A., Mai, Pham Phuong, Reynolds, Daniel K., Caws, Maxine, Dung, Nguyen Thi, Hien, Tran Tinh, Kulawy, Robert, Farrar, Jeremy, Ambrose, Paul G.
Wydane 2011